DCF Valuation Adds to LIN Overvaluation Concerns

What happened

On October 19, 2026, GuruFocus published a DCF analysis suggesting LIN is worth $245 per share, a sharp contrast to its market price near $497 after an 18.1% year-to-date gain. The article's intrinsic value estimate sits well below both the master report's base case of $490 and bear case of $390, implying the market may be pricing in overly optimistic growth. However, the DCF's underlying assumptions are not disclosed, and such models often embed conservative long-term growth and margin inputs that penalize high-quality compounders. The master report already rates LIN a WAIT with limited margin of safety at 33.4x P/E, so this external valuation reinforces the caution but does not introduce a new fundamental risk. Investors should treat the DCF as one bearish data point among many, with the key operational catalysts—project startups, helium headwinds, and restructuring—still the primary drivers of value.

Implication

Over a longer horizon, Linde's contracted backlog and productivity engine could support earnings growth, but the DCF's low estimate underscores how dependent the current premium valuation is on flawless execution. If the market begins to question the 2026 startup plan or helium pricing remains a persistent drag, LIN could face multiple compression toward levels closer to the bear case of $390, still above the DCF's $245. Investors should require a larger margin of safety: the master report's attractive entry of $450 may not be sufficient if the DCF's more pessimistic assumptions prove even partially correct. A prudent approach is to wait for either a significant price decline toward the mid-$300s or confirmation of accelerating earnings delivery before considering a position. Meanwhile, continue to monitor quarterly project startups, helium commentary, and free cash flow conversion as key signposts for whether the bearish valuation is warranted.

Thesis delta

The external DCF introduces a more bearish valuation anchor than our own bear case, suggesting that even our $390 downside scenario may not capture the full extent of potential multiple compression. However, we do not change our WAIT rating because the DCF's assumptions are unverifiable and the underlying operational thesis—project execution and helium recovery—remains unchanged. The main shift is to lower our confidence in the $450 attractive entry level; we now see greater risk that a true margin-of-safety entry requires a price below $400, particularly if helium headwinds persist.